AstraZeneca Finance and Holdings Inc. /
CinCor Pharma, Inc.
AstraZeneca Finance and Holdings Inc. completes acquisition of CinCor Pharma, Inc.
- Price
- $1.8bn
- Stage
- Closed
What happened
AstraZeneca Finance and Holdings Inc. completed its acquisition of CinCor Pharma, Inc. on Feb. 24, 2023. CinCor became a direct wholly owned subsidiary of AstraZeneca Finance and Holdings Inc.
The total transaction value, including contingent value rights, is approximately $1.8 billion.
The source
Everything on this page comes from the source below.
AstraZeneca Finance and Holdings Inc. completes acquisition of CinCor Pharma, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly